ENERGY FUELS INC
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(unaudited) (Expressed in thousands of U.S. dollars, except per share amounts)
| Three Months Ended September 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenues | ||||
| Uranium concentrates | $4,000 | $10,473 | $37,904 | $33,278 |
| Vanadium concentrates | — | — | — | 871 |
| RE Carbonate | — | 288 | — | 2,559 |
| Alternate Feed Materials, processing and other | 47 | 226 | 288 | 755 |
| Total revenues | 4,047 | 10,987 | 38,192 | 37,463 |
| Costs applicable to revenues | ||||
| Costs applicable to uranium concentrates | 1,847 | 5,266 | 16,580 | 15,318 |
| Costs applicable to vanadium concentrates | — | — | — | 551 |
| Costs applicable to RE Carbonate | — | 282 | — | 2,312 |
| Total costs applicable to revenues | 1,847 | 5,548 | 16,580 | 18,181 |
| Other operating costs and expenses | ||||
| Exploration, development and processing | 3,619 | 2,516 | 8,911 | 9,432 |
| Standby | 1,645 | 2,281 | 4,641 | 6,175 |
| Accretion of asset retirement obligations | 327 | 282 | 916 | 902 |
| Selling, general and administration | 7,060 | 7,304 | 21,333 | 20,784 |
| Transactions and integration related costs | 1,462 | — | 4,747 | — |
| Total operating loss | (11,913) | (6,944) | (18,936) | (18,011) |
| Other income (loss) | ||||
| Gain on sale of assets (Note 6) | 8 | — | 10 | 119,257 |
| Other income (loss) (Note 13) | (174) | 17,413 | 4,066 | 18,603 |
| Total other income (loss) | (166) | 17,413 | 4,076 | 137,860 |
| Net income (loss) and comprehensive income (loss) | (12,079) | 10,469 | (14,860) | 119,849 |
| Basic net income (loss) per common share (Note 10) | $(0.07) | $0.07 | $(0.09) | $0.76 |
| Diluted net income (loss) per common share (Note 10) | $(0.07) | $0.07 | $(0.09) | $0.75 |
| Net income (loss) and comprehensive income (loss) attributable to: | ||||
| Owners of the Company | $(12,060) | $10,563 | $(14,839) | $119,968 |
| Non-controlling interests | (19) | (94) | (21) | (119) |
| Net income (loss) and comprehensive income (loss) | $(12,079) | $10,469 | $(14,860) | $119,849 |
Condensed Consolidated Balance Sheets
(unaudited) (Expressed in thousands of U.S. dollars, except share amounts)
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $47,455 | $57,445 |
| Marketable securities (Notes 4 and 15) | 101,154 | 133,044 |
| Trade and other receivables, net of allowance for credit losses of $223 and $223, as of September 30, 2024 and December 31, 2023, respectively | 4,914 | 816 |
| Inventories (Note 5) | 35,910 | 38,868 |
| Prepaid expenses and other current assets | 4,490 | 2,522 |
| Total current assets | 193,923 | 232,695 |
| Mineral properties, net (Note 6) | 124,856 | 119,581 |
| Property, plant and equipment, net (Note 6) | 43,548 | 26,123 |
| Inventories (Note 5) | — | 1,852 |
| Operating lease right of use asset | 1,079 | 1,219 |
| Investments (Note 7) | 12,130 | 1,356 |
| Intellectual property (Note 3) | 4,821 | — |
| Other long-term receivables | 763 | 1,534 |
| Restricted cash (Note 8) | 19,284 | 17,579 |
| Total assets | $400,404 | $401,939 |
| LIABILITIES & EQUITY | ||
| Current liabilities | ||
| Accounts payable and accrued liabilities (Note 13) | $8,213 | $10,161 |
| Contingent consideration (Note 3) | 1,727 | — |
| Deferred revenue | 600 | — |
| Operating lease liability | 228 | 199 |
| Total current liabilities | 10,768 | 10,360 |
| Operating lease liability | 946 | 1,120 |
| Asset retirement obligations (Note 8) | 12,003 | 10,922 |
| Deferred revenue | — | 332 |
| Total liabilities | 23,717 | 22,734 |
| Equity | ||
| Share capital Common shares, without par value, unlimited shares authorized; shares issued and outstanding 164,678,756 and 162,659,155 as of September 30, 2024 and December 31, 2023, respectively | 745,792 | 733,450 |
| Accumulated deficit | (371,097) | (356,258) |
| Accumulated other comprehensive loss | (1,946) | (1,946) |
| Total shareholders' equity | 372,749 | 375,246 |
| Non-controlling interests | 3,938 | 3,959 |
| Total equity | 376,687 | 379,205 |
| Total liabilities and equity | $400,404 | $401,939 |
| Commitments and contingencies (Note 14) | ||
Condensed Consolidated Statements of Changes in Equity
(unaudited) (Expressed in thousands of U.S. dollars, except share amounts)
| Common Stock · Accumulated Earnings (Deficit) · AccumulatedOtherComprehensiveIncome (Loss) · TotalShareholders'Equity · Non-ControllingInterests · Total Equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balance as of December 31, 2023 | 162,659,155 | $733,450 | $(356,258) | $(1,946) | $375,246 | $3,959 | $379,205 |
| Net income (loss) | — | — | 3,639 | — | 3,639 | (1) | 3,638 |
| Shares issued for cash by at-the-market offering | 619,910 | 4,898 | — | — | 4,898 | — | 4,898 |
| Share issuance cost | — | (110) | — | — | (110) | — | (110) |
| Share-based compensation | — | 1,345 | — | — | 1,345 | — | 1,345 |
| Shares issued for exercise of stock appreciation rights | 89,794 | — | — | — | — | — | — |
| Cash paid to settle and fund employee income tax withholding due upon exercise of stock appreciation rights | — | (552) | — | — | (552) | — | (552) |
| Shares issued for exercise of stock options | 29,116 | 103 | — | — | 103 | — | 103 |
| Shares issued for the vesting of restricted stock units | 253,922 | — | — | — | — | — | — |
| Cash paid to fund employee income tax withholding due upon vesting of restricted stock units | — | (837) | — | — | (837) | — | (837) |
| Balance as of March 31, 2024 | 163,651,897 | $738,297 | $(352,619) | $(1,946) | $383,732 | $3,958 | $387,690 |
| Net loss | — | — | (6,418) | — | (6,418) | (1) | (6,419) |
| Share-based compensation | — | 1,412 | — | — | 1,412 | — | 1,412 |
| Shares issued for exercise of stock options | 9,214 | 53 | — | — | 53 | — | 53 |
| Balance as of June 30, 2024 | 163,661,111 | $739,762 | $(359,037) | $(1,946) | $378,779 | $3,957 | $382,736 |
| Net loss | — | — | (12,060) | — | (12,060) | (19) | (12,079) |
| Share-based compensation | — | 1,027 | — | — | 1,027 | — | 1,027 |
| Shares issued for exercise of stock options | 9,474 | 3 | — | — | 3 | — | 3 |
| Shares issued for acquisition of intangible assets | 321,197 | 1,500 | — | — | 1,500 | — | 1,500 |
| Shares issued for joint venture interests | 686,974 | 3,500 | — | — | 3,500 | — | 3,500 |
| Balance as of September 30, 2024 | 164,678,756 | $745,792 | $(371,097) | $(1,946) | $372,749 | $3,938 | $376,687 |
| Common Stock · Deficit · AccumulatedOtherComprehensiveIncome (Loss) · TotalShareholders'Equity · Non-ControllingInterests · Total Equity | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balance as of December 31, 2022 | 157,682,531 | $698,493 | $(456,120) | $(1,946) | $240,427 | $3,982 | $244,409 |
| Net income (loss) | — | — | 114,265 | — | 114,265 | (1) | 114,264 |
| Share-based compensation | — | 1,186 | — | — | 1,186 | — | 1,186 |
| Shares issued for exercise of stock options | 34,219 | 72 | — | — | 72 | — | 72 |
| Shares issued for the vesting of restricted stock units | 312,662 | — | — | — | — | — | — |
| Cash paid to fund employee income tax withholding due upon vesting of restricted stock units | — | (918) | — | — | (918) | — | (918) |
| Balance as of March 31, 2023 | 158,029,412 | $698,833 | $(341,855) | $(1,946) | $355,032 | $3,981 | $359,013 |
| Net loss | — | — | (4,861) | — | (4,861) | (24) | (4,885) |
| Share-based compensation | — | 1,554 | — | — | 1,554 | — | 1,554 |
| Shares issued for exercise of stock options | 45,126 | 312 | — | — | 312 | — | 312 |
| Shares issued for exercise of stock appreciation rights | 164,258 | — | — | — | — | — | — |
| Cash paid to settle and fund employee income tax withholding due upon exercise of stock appreciation rights | — | (848) | — | — | (848) | — | (848) |
| Balance as of June 30, 2023 | 158,238,796 | $699,851 | $(346,716) | $(1,946) | $351,189 | $3,957 | $355,146 |
| Net income (loss) | — | — | 10,563 | — | 10,563 | (94) | 10,469 |
| Share-based compensation | — | 1,293 | — | — | 1,293 | — | 1,293 |
| Shares issued for exercise of stock options | 100,522 | 247 | — | — | 247 | — | 247 |
| Shares issued for consulting services | 70,336 | 126 | — | — | 126 | — | 126 |
| Shares issued for exercise of stock appreciation rights | 5,544 | — | — | — | — | — | — |
| Shares issued for cash by at-the-market offering | 2,048,172 | 16,416 | — | — | 16,416 | — | 16,416 |
| Share issuance cost | — | (369) | — | — | (369) | — | (369) |
| Balance as of September 30, 2023 | 160,463,370 | $717,564 | $(336,153) | $(1,946) | $379,465 | $3,863 | $383,328 |
Condensed Consolidated Statements of Cash Flows
(unaudited) (Expressed in thousands of U.S. dollars)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| OPERATING ACTIVITIES | ||
| Net income (loss) | $(14,860) | $119,849 |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Depletion, depreciation and amortization | 1,999 | 2,024 |
| Share-based compensation | 3,784 | 4,033 |
| Accretion of asset retirement obligations | 916 | 902 |
| Unrealized foreign exchange (gain) loss | 331 | (85) |
| Unrealized gain on investments | — | (6,701) |
| Unrealized gain on convertible note | — | (6,972) |
| Realized gain on marketable securities | (1,704) | — |
| Gain on sale of assets | (10) | (119,257) |
| Other, net | (30) | (682) |
| Changes in current assets and liabilities: | ||
| Marketable securities | 1,346 | (875) |
| Inventories | 6,782 | 10,807 |
| Trade and other receivables | (3,384) | (10,570) |
| Prepaid expenses and other current assets | (1,948) | (1,526) |
| Accounts payable and accrued liabilities | (1,210) | (1,929) |
| Net cash used in operating activities | (7,988) | (10,982) |
| INVESTING ACTIVITIES | ||
| Additions to property, plant and equipment | (20,684) | (8,908) |
| Additions to mineral properties | (6,220) | (26,892) |
| Purchase of intangible assets | (1,639) | — |
| Purchases of marketable securities | (184,284) | (98,896) |
| Maturities of marketable securities | 216,533 | 41,931 |
| Purchase of investments | (7,306) | — |
| Proceeds from sale of assets | 10 | 56,873 |
| Proceeds from convertible note redemption | — | 20,000 |
| Net cash used in investing activities | (3,590) | (15,892) |
| FINANCING ACTIVITIES | ||
| Issuance of common shares for cash, net of issuance costs | 4,788 | 16,047 |
| Cash paid to fund employee income tax withholding due upon vesting of restricted stock units | (837) | (918) |
| Cash received from exercise of stock options | 159 | 757 |
| Cash paid to settle and fund employee income tax withholding due upon exercise of stock appreciation rights | (552) | (848) |
| Net cash provided by financing activities | 3,558 | 15,038 |
| Effect of exchange rate fluctuations on cash held in foreign currencies | (265) | 33 |
| Plus: release of restricted cash related to sale of assets | — | 3,590 |
| Net change in cash, cash equivalents and restricted cash | (8,285) | (8,213) |
| Cash, cash equivalents and restricted cash, beginning of period | 75,024 | 80,269 |
| CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD | $66,739 | $72,056 |
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Supplemental disclosure of cash flow information: | ||
| Cash paid during the period for interest | $141 | $13 |
| Increase (decrease) in accounts payable and accrued liabilities for property, plant and equipment and mineral properties | $(464) | $697 |
| Non-cash investing and financing transactions: | ||
| Shares issued for joint venture interests | $3,500 | $— |
| Shares issued for acquisition of intangible assets | $1,500 | $— |
| Contingent consideration for acquisition of intangible assets | $1,690 | $— |
| Acquisition of convertible note | $— | $59,259 |
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited) (Tabular amounts expressed in thousands of U.S. dollars, except share and per share amounts)
- THE COMPANY AND DESCRIPTION OF BUSINESS
Energy Fuels Inc. was incorporated under the laws of the Province of Alberta and was continued under the Business Corporations Act (Ontario).
Energy Fuels Inc. and its subsidiary companies (collectively the “Company” or “Energy Fuels”) are together engaged in conventional andin situ recovery (“ISR”) uranium extraction, recovery and sales of uranium from mineral properties and the recycling of uranium-bearing materials generated by third parties, along with the exploration, permitting and evaluation of uranium properties in the United States (the “U.S.”). As a part of these activities, the Company also acquires, explores, evaluates and, if warranted, permits uranium properties. The Company’s final uranium product, uranium oxide concentrate (“U 3 O 8” or “uranium concentrate”), also known as “yellowcake,” is sold to customers for further processing into fuel for nuclear reactors. The Company also produces vanadium pentoxide (“V 2 O 5”) as a co-product of uranium at the White Mesa Mill (the “White Mesa Mill” or the “Mill”), from certain of its Colorado Plateau properties and at times from solutions in its Mill tailings impoundment system, each as market conditions warrant. The Mill has produced rare earth elements (“REE”) carbonate (“RE Carbonate”) from various uranium- and REE-bearing materials acquired from third parties since 2021 and completed modifications and enhancements to its existing infrastructure for the production of separated REE products, producing separated neodymium/praseodymium (“NdPr”) in 2024.
The Company owns the Bahia Project in Brazil, which is an exploration/permitting stage property for the potential production of heavy mineral sands (“HMS”) that would be sold into the commercial HMS market while the associated monazite would be used as a feedstock ore for production of REEs and uranium at the Mill. On October 2, 2024, the Company acquired Base Resources Limited (“Base” or “Base Resources”) increasing its portfolio of other HMS/monazite/REE projects around the world (see Note 18 – Subsequent Events). Additionally, the Company is evaluating the potential to recover radioisotopes from its existing uranium process streams at the Mill for use in targeted alpha therapy (“TAT”) therapeutics for the treatment of cancer with RadTran LLC (“RadTran”) (See Note 3 – Transactions).
With its uranium, vanadium, REE, HMS and potential radioisotope production, the Mill is working to establish itself as a critical minerals hub in the U.S.
Energy Fuels produces both uranium and REEs. Uranium is the fuel for carbon-free, emission-free baseload nuclear power – one of the cleanest forms of energy in the world; REEs are used to manufacture permanent magnets for electric vehicles (“EVs”), wind turbines and other clean energy and modern technologies. Concurrently, the Company’s recycling program (which includes processing Alternate Feed Materials, recycling tailings solutions and performing other activities for the recovery of uranium, vanadium and potentially other metals and radionuclides) works to reduce the levels of new production and natural disturbances needed to meet global energy demand by recycling feed sources that would have otherwise been lost to direct disposal and extracting additional valuable minerals from them. Through its uranium and REE production and long-standing recycling program, Energy Fuels works to help address global climate change by producing materials that ultimately reduce reliance on carbon dioxide (“CO 2”) emitters, such as fossil fuels, while also ensuring that materials already extracted but only partially utilized are instead used to the fullest extent practicable so as to limit the global mining footprint and reduce the number of constituents ultimately disposed of. Additionally, certain radioisotopes, which the Company is evaluating for recovery from its uranium processing streams, have the potential to provide the isotopes needed for emerging TAT cancer-fighting therapeutics.
As of September 30, 2024, the Company is a “production stage issuer” as defined by S-K 1300, as it is engaged in the material extraction of mineral reserves on at least one material property.
Mining Activities
The Company’s mining activities consist of the Mill, multiple conventional mining projects and an ISR mining project (complete with an ISR recovery facility on standby). The conventional mining projects are located on the Colorado Plateau, including the Pinyon Plain, Whirlwind, La Sal, Bullfrog, Arizona Strip and Roca Honda Projects, all of which are in the vicinity of the Mill, as well as the Sheep Mountain Project located in Wyoming and the Bahia Project (defined in Note 6 – Property, Plant and Equipment and Mineral Properties) located in Brazil. The Company’s Nichols Ranch Project (including the Jane Dough and Hank Satellite deposits) is an ISR project located in Wyoming.
As of September 30, 2024, the Company continued ore production at its Pinyon Plain, La Sal and Pandora Projects, as well as exploration drilling and analysis at its Nichols Ranch and Bahia Projects. Other conventional mining projects in the vicinity of the Mill, as well as the Sheep Mountain Project, are on standby and are being evaluated for continued mining and other activities and/or are in the process of being permitted. The Mill continues to receive third-party uranium-bearing mineralized materials from mining and other industry activities for its own processing and recycling, while also expanding its REE initiatives and pursuing its TAT cancer-fighting therapeutics initiatives. On October 2, 2024, the Company acquired the Kwale HMS Project in Kenya and the Toliara HMS Project in Madagascar as part of its acquisition of Base Resources on October 2, 2024. See Note 18 – Subsequent Events.
- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
These unaudited condensed consolidated financial statements included herein have been prepared by the Company pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) applicable to interim financial information and should be read in conjunction with the consolidated financial statements and notes thereto and the summary of significant accounting policies included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on February 23, 2024, as amended June 28, 2024.
These unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information, and, accordingly, do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. These unaudited condensed consolidated financial statements are presented in thousands of U.S. dollars, except for share and per share amounts. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures included are adequate to make the information presented not misleading.
In management’s opinion, these unaudited condensed consolidated financial statements reflect all adjustments, consisting solely of normal recurring items, which are necessary for the fair presentation of the Company’s financial position, results of operations and cash flows on a basis consistent with that of the Company’s audited consolidated financial statements for the year ended December 31, 2023. However, the results of operations for the interim periods may not be indicative of results to be expected for the full fiscal year.
Principles of Consolidation
These unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany accounts and transactions have been eliminated. The Company reports operating and financial results in a single segment based on the consolidated information used by the chief operating decision maker (“CODM”), who is the Company's Chief Executive Officer, in evaluating the financial performance of our business and allocating resources. This single segment reflects the Company's core business: the production of uranium and critical minerals. As the Company has one reportable segment, net income, total assets and working capital are equal to consolidated results. The CODM primarily uses operating expenses to manage operations.
Recently Adopted Accounting Standard
In November 2023, the FASB issued Accounting Standard Update (“ASU”) 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures.” This ASU requires annual and interim disclosures about significant segment expenses that are regularly provided to the CODM and included within each reported measure of segment profit or loss as well as the amount and composition of other segment items. The Company adopted this standard prospectively on January 1, 2024, which did not have a material impact on the Company's unaudited condensed consolidated financial statements.
- TRANSACTIONS
Joint Venture with Astron on the Donald Project
On June 3, 2024, the Company executed binding agreements (collectively, the “JV Agreements”) with Astron Corporation Limited (“Astron”) for the creation of a joint venture (the “Donald Project JV”) to jointly develop and operate the Donald Rare Earth and Mineral Sands Project in Australia (the “Donald Project”). The Donald Project is a well-known HMS and rare earth deposit that the Company believes could provide it with another near-term, low-cost, and large-scale source of monazite sand that would be transported to the Mill for the recovery of separated REE products along with the contained uranium. The Donald Project has most licenses and permits in place (or at an advanced stage of completion). The JV Agreement provides Energy Fuels the right to invest up to AUS$183 million (approximately $127 million at September 30, 2024 exchange rates) to earn up to a 49% interest in the Donald Project JV, of which approximately $10.6 million is expected to be invested in 2024 in preparation of a final investment decision (“FID”), and, if a positive FID is made, the remainder would be invested to develop the project and to earn into the full 49% interest in the Donald Project JV. In addition, the Company would issue Energy Fuels common shares (“Common Shares”) to Astron having a value of up to $17.5 million, of which $3.5 million of Common Shares were issued September 24, 2024 upon the satisfaction of certain conditions precedent (the “Completion Issuance”) and the remainder would be issued upon a positive FID. On September 25, 2024, the Donald Project JV was established and the Company earned an initial 3.21% interest in the Donald Project in exchange for the Completion Issuance and for funds invested in the Donald Project to that date. Astron, through its subsidiary Dickson & Johnson Pty Ltd, holds the remaining 96.79% interest.
The Company evaluated whether the Donald Project JV is a variable interest entity (“VIE”). Variable interests can be contractual, ownership or other pecuniary interests in an entity that change with changes in the fair value of the VIE’s assets. Based on its qualitative and quantitative contractual rights under the JV Agreements, Energy Fuels has a variable interest in the Donald Project JV. Additionally, the Company has determined that it does not have a controlling financial interest in the Donald Project JV because it does not have: (i) the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance, and (ii) the obligation to absorb losses that could potentially be significant to the VIE or the right to receive benefits that could potentially be significant to the VIE as its ownership is less than 10% of the Donald Project JV. As of June 3, 2024, the Company had elected to account for the Donald Project JV as an investment without a readily determinable fair value at cost less impairment, and this investment is included in Investments on its unaudited Condensed Consolidated Balance Sheet. Upon Completion Issuance, the Company elected to account for the Donald Project JV as an equity method investment because the Company earned an initial 3.21% interest in the Donald Project and it exercises significant influence, but not control, over the entity. This investment is included in Investments on the Company's unaudited Condensed Consolidated Balance Sheet. The Company’s maximum exposure to loss on the Donald Project JV was $9.31 million as of September 30, 2024. Changes in the design or nature of the activities of the Donald Project JV, or the Company’s involvement with the Donald Project JV, may require the Company to reconsider its conclusions on the entity’s status as a VIE and/or whether the Company is not the primary beneficiary.
Acquisition of RadTran
On August 16, 2024, the Company acquired RadTran, a private company specializing in the separation of critical radioisotopes, to further the Company’s plans for development and production of medical isotopes used in cancer treatments. RadTran’s expertise includes separation of radium-226 (“Ra-226”) and radium-228 (“Ra-228”) from uranium and thorium process streams. This acquisition is expected to significantly enhance Energy Fuels’ planned capabilities to address the global shortage of these essential isotopes used in emerging TATs for cancer treatment.
Since July 2021, Energy Fuels and RadTran have been working under a Strategic Alliance Agreement to evaluate the feasibility of recovering Ra-226 and Ra-228 from existing uranium process streams at the Mill. Recovered Ra-226 and Ra-228 would be made available to the pharmaceutical industry and others to enable the production of actinium-225 (“Ac-225”), lead-212 (“Pb-212”) and potentially other leading medically attractive TAT isotopes. These isotopes are critical components in the development of targeted alpha therapies, which offer promising new treatments for various cancers. The global shortage of Ra-226 and Ra-228 currently presents itself as a significant barrier to the advancement and commercialization of these therapies. Energy Fuels received regulatory approval and licensing in 2023 for the concentration of research and development (“R&D”) quantities of Ra-226 at the Mill and is currently completing engineering on its R&D pilot facility for Ra-226 production.
Under the Acquisition, the purchase price paid by Energy Fuels to the owners of RadTran consisted of (all dollar amounts in US$): (i) on closing, $1.50 million in cash, $1.50 million in Common Shares and the grant of a 2% royalty on future revenues from the sale of produced radium, as well as certain other contractual commitments; and up to an additional $14.00 million total in cash and Common Shares based on the satisfaction of a number of performance-based milestones, including (i) $1.00 million in cash and $1.00 million in Common Shares upon achieving initial production; (ii) $1.00 million in cash and $1.00 million in Common Shares upon securing suitable offtake agreements to justify commercial production; and (iii) $10.00 million in cash upon reaching commercial production. As of September 30, 2024, the Company believes it is probable it will achieve the milestone related to achieving initial production.
In accordance with Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”), the Company has accounted for the acquisition of RadTran as an asset acquisition as substantially all of the fair value of the assets acquired was concentrated in a group of similar identifiable assets. The purchase consideration includes cash paid at closing, common shares issued at closing, the fair value contingent consideration related to achieving initial production (see Note 15 – Fair Value), plus transaction costs, which was allocated to the acquired intellectual property. The contingent consideration is classified as a liability at its estimated fair value at each reporting period with subsequent revaluations recognized as an adjustment to the Intellectual property and Contingent consideration on the unaudited condensed combined Balance Sheet with a cumulative amortization adjustment. The total purchase consideration as of August 16, 2024 was $4.83 million calculated as follows:
| Cash | $1,500 |
|---|---|
| Issuance of Common Shares | 1,500 |
| Fair value of contingent consideration | 1,690 |
| Direct transaction costs | 139 |
| Total purchase consideration | $4,829 |
Intellectual property is amortized on a straight-line basis over a weighted average life of 13.5 years.
The following is a summary of intellectual property, net:
| Intellectual property, as of August 16, 2024 | $4,829 |
|---|---|
| Increase in fair value of contingent consideration | 37 |
| Amortization | (45) |
| Intellectual property, as of September 30, 2024 | $4,821 |
- MARKETABLE SECURITIES
The Company has elected the fair value option for its marketable debt securities and records these instruments on the Condensed Consolidated Balance Sheet at their fair value including interest income. Changes in fair value and interest income are recorded in Other income in the Condensed Consolidated Statements of Operations and Comprehensive Income. The fair value option was elected for these marketable debt securities, as the Company may sell them prior to their stated maturities after consideration of the Company’s risk versus reward objectives, as well as its liquidity requirements. The stated contractual maturity dates of marketable debt securities held as of September 30, 2024 and December 31, 2023 are due in one to two years. Marketable equity securities are measured at fair value as of each reporting date, and realized and unrealized gains (losses) and interest income are recorded in Other income in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).
The following table summarizes our marketable securities by significant investment categories:
| Cost Basis | Gross Unrealized Losses | Gross Unrealized Gains | Fair Value | |
|---|---|---|---|---|
| Marketable debt securities(1) | $76,247 | $— | $1,086 | $77,333 |
| Marketable equity securities | 28,159 | (4,338) | — | 23,821 |
| Total marketable securities | $104,406 | $(4,338) | $1,086 | $101,154 |
| Marketable debt securities(1) | $106,791 | $— | $675 | $107,466 |
| Marketable equity securities | 28,159 | (2,581) | — | 25,578 |
| Total marketable securities | $134,950 | $(2,581) | $675 | $133,044 |
(1) Marketable debt securities are comprised primarily of U.S. Treasury Bills and Government Agency Bonds.
- INVENTORIES
Inventories consisted of the following items:
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Concentrates and work-in-progress | $15,095 | $35,807 |
| Inventory of ore in stockpiles | 15,895 | 3,072 |
| Raw materials and consumables | 4,920 | 1,841 |
| Total inventories | $35,910 | $40,720 |
- PROPERTY, PLANT AND EQUIPMENT AND MINERAL PROPERTIES
Property, Plant and Equipment
The following is a summary of property, plant and equipment, net:
| Estimated | |||
|---|---|---|---|
| Useful Lives | September 30, 2024 | December 31, 2023 | |
| Land | N/A | $642 | $642 |
| Plant facilities | 12 - 15 years | 50,451 | 29,750 |
| Mining equipment | 5 - 10 years | 21,471 | 13,019 |
| Light trucks and utility vehicles | 5 years | 3,905 | 3,256 |
| Office furniture and equipment | 4 - 7 years | 1,909 | 1,754 |
| Construction-in-progress(1) | N/A | 4,203 | 13,627 |
| Total property, plant and equipment | $82,581 | $62,048 | |
| Less: accumulated depreciation | (39,033) | (35,925) | |
| Property, plant and equipment, net | $43,548 | $26,123 | |
(1) Costs incurred for commissioning activities for the Company’s Phase 1 REE separation circuit at the Mill are capitalized. The Company will offset these costs upon sale of separated neodymium-praseodymium (“NdPr”) that is produced during commissioning of the Phase 1 REE separation circuit.
The Company recognized depreciation expense of $0.66 million and $0.69 million for the three months ended September 30, 2024 and 2023, respectively, and $1.95 million and $2.02 million for the nine months ended September 30, 2024, and 2023, respectively. Depreciation expense is included in Exploration, development and processing as well as Standby in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).
For the three months ended September 30, 2024 and 2023, the Company capitalized $0.46 million and $0.09 million of depreciation expense to inventory related to the Mill and production activities on the Condensed Consolidated Balance Sheets, respectively. For the nine months ended September 30, 2024 and 2023, the Company capitalized $0.94 million and $0.24 million, respectively, of depreciation expense to inventory related to the Mill on the Condensed Consolidated Balance Sheets.
For the three months ended September 30, 2023, the Company capitalized $0.06 million of depreciation expense to mineral properties on the Condensed Consolidated Balance Sheet. No depreciation expense was capitalized to mineral properties for the three months ended September 30, 2024. For the nine months ended September 30, 2024 and 2023, the Company capitalized $0.23 million and $0.13 million, respectively, of depreciation expense to mineral properties on the Condensed Consolidated Balance Sheet.
Mineral Properties
The following is a summary of mineral properties:
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Sheep Mountain | $34,183 | $34,183 |
| Bahia Project | 32,613 | 29,130 |
| Nichols Ranch ISR Project | 25,974 | 25,974 |
| Roca Honda | 22,095 | 22,095 |
| Pinyon Plain | 9,338 | 6,512 |
| Other | 1,687 | 1,687 |
| Total mineral properties | $125,890 | $119,581 |
| Less: accumulated depletion | $(1,034) | $— |
| Mineral properties, net | $124,856 | $119,581 |
Capitalized costs to mineral properties are depleted using the units-of-production method (“UOP”) over the estimated life of the ore body based on estimated recoverable material to be produced from proven and probable reserves.
The calculation of the UOP rate of depletion could be materially impacted to the extent that actual production in the future is different from current forecasts of production based on proven and probable reserves. This would generally occur to the extent that there were significant changes in any of the factors or assumptions used in determining reserves. These changes could include: (i) an expansion of proven and probable reserves through exploration activity; (ii) differences between estimated and actual costs of production, due to differences in grade, recovery rates and foreign currency exchange rates; and (iii) differences between actual commodity prices and commodity price assumptions used in the estimation of reserves. If reserves decreased significantly, UOP depletion charged to operations would increase; conversely, if reserves increased significantly, UOP depletion charged to operations would decrease. Such changes in reserves could similarly impact the useful lives of assets depreciated on a straight-line basis, where those lives are limited to the life of the mine, which in turn is limited to the life of proven and probable reserves.
The expected useful lives used in depletion, depreciation and amortization calculations are determined based on the applicable facts and circumstances, as described above. As judgement is involved in the determination of useful lives, no assurance can be given that actual useful lives will not differ significantly from the useful lives assumed for the purpose of depletion, depreciation and amortization calculations.
Bahia Project
On February 10, 2023, the Company closed ontwo purchase agreements to acquire a total of 17 mineral concessions in the State of Bahia, Brazil totaling approximately 37,300 acres or 58.3 square miles (the “Bahia Project”). Under the terms of the purchase agreements, the Company entered into mineral rights transfer agreements with the sellers to acquire the 17 heavy mineral sands concessions.
The total purchase price under the purchase agreements was $27.50 million, which consisted of deposit payments of $5.90 million due upon reaching certain stipulated milestones and the remaining $21.60 million due at closing. Upon final payment on February 10, 2023, the transfer and assignment of the mineral rights was completed (the “Bahia Closing”). Additionally, the Company incurred direct deal costs related to such asset acquisitions of $1.63 million. The Bahia Closing followed the Brazilian Government’s approval of the transfers to Energy Fuels’ wholly owned Brazilian subsidiary Energy Fuels Brazil Ltda.
Alta Mesa Transaction
On February 14, 2023, the Company closed on its sale to enCore Energy Corp. (“enCore”) ofthree wholly-owned subsidiaries that together held Alta Mesa for total consideration of $120 million (the “Alta Mesa Transaction”), paid as follows:
a.$60 million in cash, which included $6 million prior to closing and $54 million at closing; and
b. a $60 million secured convertible note (“Convertible Note”), payable intwo years from the closing, bearing annual interest of eight percent (8%). The Convertible Note is convertible at Energy Fuels’ election into fully paid and non-assessable enCore common shares at a conversion price of $2.9103 per share, being a 20% premium to the 10-day volume-weighted average price of enCore shares ending the day before the Closing (the “Conversion Option”). enCore is currently traded on the TSX-V and NYSE American. The Convertible Note is guaranteed by enCore and fully secured by Alta Mesa. Unless a block trade or similar distribution is executed by Energy Fuels to sell the enCore common shares received on conversion of the Convertible Note, Energy Fuels will be limited to selling a maximum of $10 million of enCore common shares per thirty (30)-day period.
The Company recognized a gain on sale of assets from the Alta Mesa Transaction of $116.50 million, which was calculated as the total fair value of the consideration received of $119.46 million consisting of $60 million in cash and the Convertible Note with a fair value of $59.46 million, less the net book value attributable to the Alta Mesa assets and liabilities after working capital adjustments of $3.40 million, net of transaction costs. Receipt of the Convertible Note represents a non-cash investing activity at its initial fair value. See Note 15 – Fair Value Accounting for more information on the fair value and current status of the Convertible Note.
As a post-closing condition of the Alta Mesa Transaction, enCore was required to replace the $3.59 million of reclamation bonds then in place for Alta Mesa. Upon replacement, the original bonds were released and the Company received back the underlying collateral. The Company reclassified $3.59 million cash as a release of collateral from those bonds from Property, plant and equipment and other assets held for sale, net to cash and cash equivalents on its Condensed Consolidated Balance Sheets.
In connection with the Alta Mesa Transaction, on May 3, 2023, the Company completed the sale of its Prompt Fission Neutron assets, including the underlying contracts, technology, licenses and intellectual property (collectively, the “PFN Assets”), to enCore in exchange for cash consideration received at closing of $3.10 million, which resulted in a gain of $2.75 million. At closing, the PFN Assets, which the Company had purchased in 2020 for cash consideration of $0.50 million, had a net book value of $0.35 million. The PFN Assets were used exclusively at the Alta Mesa ISR Project. Should the Company have the need for the use of a PFN tool in the future, the Company retained a 20-year usage right as a condition of this sale during which, subject to the availability of the PFN Assets, the Company has the right to purchase, lease and/or license at least one fully functional PFN tool and all related and/or required equipment, technology and licenses, as reasonably requested, on commercially reasonable terms and conditions no less favorable than those offered by enCore to third parties. As of September 30, 2024, the Company has not purchased, leased and/or licensed a PFN tool.
- INVESTMENTS
The Company’s investments include its equity method investment in the Donald Project JV and investments without readily determinable fair values. The following table is a reconciliation of the Company's investments:
| September 30,2024 | December 31,2023 | |
|---|---|---|
| Equity method investment | $9,306 | $— |
| Investments without readily determinable fair values | 2,824 | 1,356 |
| Total investments | $12,130 | $1,356 |
- ASSET RETIREMENT OBLIGATIONS AND RESTRICTED CASH
Asset Retirement Obligations
The following table summarizes the Company’s asset retirement obligations:
| Asset retirement obligations, December 31, 2023 | $10,922 |
|---|---|
| Revision of estimate | 165 |
| Accretion of liabilities | 916 |
| Asset retirement obligations, September 30, 2024 | $12,003 |
The Company’s asset retirement obligations are subject to legal and regulatory requirements. Estimates of the costs of reclamation are reviewed periodically by the Company and the applicable regulatory authorities.
The upward revision of the estimate of $0.17 million for the nine months ended September 30, 2024 includes net changes in estimated costs of future reclamation activities. These revisions were recognized in Property, plant and equipment, net on the Consolidated Balance Sheet and will be depreciated over the useful life of the related asset.
Restricted Cash
The Company has cash, cash equivalents and fixed income securities as collateral for various bonds posted in favor of the applicable state regulatory agencies in Arizona, Colorado, New Mexico, Utah and Wyoming, and the U.S. Bureau of Land Management and U.S. Forest Service for estimated reclamation costs associated with the White Mesa Mill, Nichols Ranch and other mining properties. The restricted cash will be released when the Company has reclaimed a mineral property, sold a mineral property to a party having assumed the applicable bond requirements, or restructured the surety and collateral arrangements. See Note 14 – Commitments and Contingencies for more information.
The following table summarizes the Company’s restricted cash:
| Restricted cash, December 31, 2023 | $17,579 |
|---|---|
| Additional collateral posted | 1,705 |
| Restricted cash, September 30, 2024 | $19,284 |
- CAPITAL STOCK
Authorized Capital Stock
The Company is authorized to issue an unlimited number of Common Shares without par value, unlimited Preferred Shares issuable in series and unlimited Series A Preferred Shares. The Preferred Shares issuable in series will have the rights, privileges, restrictions and conditions assigned to the particular series upon the Board of Directors approving their issuance. The Series A Preferred Shares issuable are non-redeemable, non-callable, non-voting and have no right to dividends.
Issued Capital Stock
During the nine months ended September 30, 2024, the Company issued 0.62 million Common Shares under its at-the-market (the “ATM”) public offering program for net proceeds of $4.78 million after share issuance costs. No Common Shares were issued pursuant to the ATM during the three months ended September 30, 2024. During the three and nine months ended September 30, 2023, the Company issued 2.05 million Common Shares for net proceeds of $16.05 million pursuant to the ATM.
- BASIC AND DILUTED NET INCOME (LOSS) PER COMMON SHARE
Basic and diluted net income (loss) per Common Share
The calculation of basic net income (loss) per common share and diluted net income (loss) per common share after adjustment for the effects of all potential dilutive Common Shares is as follows:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Net income (loss) attributable to owners of the Company | $(12,060) | $10,563 | $(14,839) | $119,968 |
| Basic weighted average common shares outstanding | 163,882,537 | 158,616,883 | 163,650,699 | 158,235,301 |
| Dilutive impact of stock options and restricted stock units | — | 1,167,832 | — | 1,217,624 |
| Diluted weighted average common shares outstanding | 163,882,537 | 159,784,715 | 163,650,699 | 159,452,925 |
| Basic net income (loss) per common share | $(0.07) | $0.07 | $(0.09) | $0.76 |
| Diluted net income (loss) per common share | $(0.07) | $0.07 | $(0.09) | $0.75 |
For the three months ended September 30, 2024 and 2023, a weighted average of 1.71 million and 0.78 million, respectively, stock options and restricted stock units (“RSUs”) have been excluded from the calculation of diluted net income per common share, as their effect would have been anti-dilutive. For the nine months ended September 30, 2024 and 2023 a weighted average of 1.61 million and 0.01 million respectively, stock options and RSUs have been excluded from the calculation of diluted net income per common share, as their effect would have been anti-dilutive. In addition, the Company excluded stock appreciation rights (“SARs”) of 1.02 million and 2.17 million, respectively, for the three months ended September 30, 2024 and 2023, as well as 1.02 million and 2.24 million, respectively, for the nine months ended September 30, 2024 and 2023 as they are contingently issuable based on specified market prices of the Company’s Common Shares, which were not achieved as of the end of each period.
- SHARE-BASED COMPENSATION
The Company maintains an equity incentive plan, known as the 2024 Amended and Restated Omnibus Equity Incentive Compensation Plan (as most recently amended and approved by the Company’s Board of Directors on May 24, 2024 and ratified by the Company’s shareholders at its Annual General and Special Meeting of Shareholders held on June 11, 2024) (the “Compensation Plan”), for directors, executives, eligible employees and consultants. Existing equity incentive awards include employee non-qualified stock options, RSUs and SARs. The Company issues new Common Shares to satisfy exercises and vesting under its equity incentive awards. Under the Compensation Plan, full value awards mean any award other than employee non-qualified stock options, SARs or similar awards, the value of which non-qualified stock options, SARs or similar award is based solely on an increase in the value of the Common shares over the grant price, option price or similar exercise price applicable to such award (“Full Value Awards”). The number of Common Shares reserved for issuance to participants under the Compensation Plan shall not exceed 10,000,000 (the “Total Share Authorization”). In addition to being subject to the Total Share Authorization limit, the aggregate number of Shares that may be issued under all Full Value Awards shall not exceed 7,500,000 (the “Full Value Share Authorization”). As of September 30, 2024, the total Common Shares authorized for future equity incentive plan awards was 7,230,770 Common Shares under the Total Share Authorization and 6,825,193 Common Shares under the Full Value Share Authorization.
The Company’s share-based compensation expense, by type of award, is as follows:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| RSUs(1) | $636 | $523 | $2,218 | $2,329 |
| SARs | 4 | 653 | 268 | 1,393 |
| Stock options | 387 | 117 | 1,298 | 311 |
| Total share-based compensation expense(2) | $1,027 | $1,293 | $3,784 | $4,033 |
(1)The fair value of the RSUs granted under the Compensation Plan for the three and nine months ended September 30, 2024 and 2023 was estimated at the date of grant using the stated market price on the NYSE American.
(2)Share-based compensation is included in Selling, general and administration in the Condensed Consolidated Statements of Operations and Comprehensive Income.
As of September 30, 2024, there were $1.57 million, $0.03 million and $0.94 million of unrecognized compensation costs related to the unvested RSUs, SARs, and stock options, respectively. This expense is expected to be recognized over a weighted average period of 2.08 years,0.28 years and 1.35 years, respectively.
Restricted Stock Units
The Company grants RSUs to directors, executives and eligible employees. Awards for executives and eligible employees are determined as a target percentage of base salary and generally vest over three years. Holders of unvested RSUs do not have voting rights on those RSUs. The RSUs are subject to forfeiture risk and other restrictions. Upon vesting, the employee is entitled to receive one Common Share of the Company for each RSU at no additional payment.
A summary of the Company’s unvested RSU activity is as follows:
| Number of Shares | Weighted Average Grant Date Fair Value | |
|---|---|---|
| Unvested, December 31, 2023 | 641,839 | $6.57 |
| Granted | 406,035 | 7.25 |
| Vested | (373,067) | 6.20 |
| Forfeited | — | — |
| Unvested, September 30, 2024 | 674,807 | $7.19 |
The total fair value of RSUs that vested and were settled for equity was $2.72 million for the nine months ended September 30, 2024.
Stock Appreciation Rights
The Company has granted SARs to executives and eligible employees from time-to-time.
Most recently, on January 26, 2023, the Company’s Board of Directors issued SARs under the Compensation Plan, which are intended to provide additional long-term equity incentives for the Company’s senior management.
Each SAR granted vests on the satisfaction of certain performance goals, and once vested, entitles the holder to receive, upon a valid exercise, payment from the Company in cash or Common Shares (at the sole discretion of the Company) in an amount representing the difference between the fair market value (“FMV”) of the Company’s Common Shares on the date of exercise and grant price. Fair Market Value as used herein means the closing price of the Common Shares on the TSX or the NYSE American on the last trading day immediately prior to the date of exercise.
A summary of the Company’s SARs activity is as follows:
| Number of Shares · Weighted AverageExercise Price · Weighted Average Remaining Contractual Life (Years) · Intrinsic Value | |||||
|---|---|---|---|---|---|
| Outstanding, December 31, 2023 | 1,839,528 | $5.01 | |||
| Granted | — | — | |||
| Exercised | (250,036) | 2.92 | |||
| Forfeited | (3,152) | 7.36 | |||
| Expired | (569,595) | 2.94 | |||
| Outstanding, September 30, 2024 | 1,016,745 | $6.67 | 2.55 | $— | |
| Exercisable, September 30, 2024 | — | $— | — | $— | |
A summary of the Company’s unvested SARs activity is as follows:
| Number of Shares | Weighted Average Grant Date Fair Value | |
|---|---|---|
| Unvested, December 31, 2023 | 1,589,492 | $2.89 |
| Granted | — | — |
| Vested | — | — |
| Expired | (569,595) | 1.22 |
| Forfeited | (3,152) | 3.45 |
| Unvested, September 30, 2024 | 1,016,745 | $3.83 |
Employee Stock Options
The Company, under the Compensation Plan, may grant stock options to directors, executives, employees and consultants to purchase Common Shares of the Company. The exercise price of the stock options is set as the higher of the Company’s closing share price on the NYSE American on the last trading day before the date of grant and the five-day VWAP on the NYSE American ending on the last trading day before the grant date. Stock options granted under the Compensation Plan generally vest over a period oftwo years or more and are generally exercisable over a period offive years from the grant date, such period not to exceed 10 years.
In January 2024, the Company granted stock options to its executives and certain other high-level employees stock options intended to incentivize senior management to achieve the Company’s strategic long-term goals over the specified terms of the grants, based on significant common share price growth objectives, and to reward management for achieving those growth objectives. The grant entitles the recipients to purchase one Common Share of the Company at an exercise price of $8.23 per share (the “Performance-Based Options”), being a 10% premium to the higher of (i) the VWAP of the Common Shares of the Company on the NYSE American for the five trading days ending on the last trading day prior to the date of the meeting when granted, and (ii) the closing price of the common shares of the Company on the NYSE American on the last trading day prior to the date of such meeting, which, as of January 24, 2024, was $7.48. The Performance-Based Options vest as to 50% on January 25, 2025 and as to the remaining 50% on January 25, 2026. The term of the Performance-Based Options is five years, ending on January 24, 2029.
The fair value of all stock options, including Performance Based Options, granted under the Compensation Plan for the nine months ended September 30, 2024 was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:
| Risk-free interest rate | 4.67% |
|---|---|
| Expected life | 3.09 |
| Expected volatility(1) | 68.82% |
| Expected dividend yield | —% |
| Weighted average grant date fair value | $3.44 |
(1)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the stock options.
A summary of all of the Company’s stock option activity, including Performance Based Options, is as follows:
| Range of Exercise Prices | Number of Shares | Weighted AverageExercise Price | Weighted Average Remaining Contractual Life (Years) | Intrinsic Value | |
|---|---|---|---|---|---|
| Outstanding, December 31, 2023 | $1.76 - $8.60 | 523,468 | $4.48 | ||
| Granted | 5.09 - 8.23 | 626,437 | 7.55 | ||
| Exercised | 1.76 - 6.47 | (47,804) | 3.32 | ||
| Forfeited | 6.12 - 8.23 | (30,012) | 7.35 | ||
| Expired | 2.92 - 7.36 | (5,885) | 6.57 | ||
| Outstanding, September 30, 2024 | $1.76 - $8.60 | 1,066,204 | $6.25 | 3.15 | $751 |
| Exercisable, September 30, 2024 | $1.76 - $8.41 | 399,742 | $4.08 | 1.39 | $739 |
A summary of the Company’s unvested stock option activity is as follows:
| Number of Shares | Weighted Average Grant Date Fair Value | |
|---|---|---|
| Unvested, December 31, 2023 | 169,182 | $4.11 |
| Granted | 626,437 | 3.44 |
| Vested | (99,145) | 4.32 |
| Forfeited | (30,012) | 3.67 |
| Unvested, September 30, 2024 | 666,462 | $3.47 |
- INCOME TAXES
As of September 30, 2024, the Company maintained a full valuation allowance against its net deferred tax assets. The Company continually reviews the adequacy of the valuation allowance and intends to continue maintaining a full valuation allowance on its net deferred tax assets until there is sufficient evidence to support the reversal of all or a portion of the allowance. Should the Company’s assessment change in a future period, it may release all or a portion of the valuation allowance, which would result in a deferred tax benefit in the period of adjustment.
For the three and nine months ended September 30, 2024, the Company didnot record income tax benefit on loss before tax of $12.08 million and $14.86 million, respectively. For the three and nine months ended September 30, 2023, the Company didnot record income tax expense on income before tax of $10.47 million and $119.85 million, respectively. The effective tax rate was 0% for the three and nine months ended September 30, 2024 and 2023, which was a result of the full valuation allowance on net deferred tax assets.
- SUPPLEMENTAL FINANCIAL INFORMATION
The components of other income (loss) are as follows:
| Three Months EndedSeptember 30, | Nine Months EndedSeptember 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Unrealized gain on investments | $— | $8,890 | $— | $6,701 |
| Unrealized gain (loss) on marketable securities | (2,330) | 540 | (1,346) | 875 |
| Realized gain on maturities of marketable securities | 843 | 374 | 1,704 | 588 |
| Unrealized gain on convertible note | — | 7,223 | — | 6,972 |
| Realized gain on convertible note | — | 181 | — | 181 |
| Foreign exchange gain (loss) | 22 | (239) | (331) | 80 |
| Interest income, net and other | 1,291 | 444 | 4,039 | 3,206 |
| Other income | $(174) | $17,413 | $4,066 | $18,603 |
The components of trade and other receivables are as follows:
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Trade receivables | $4,345 | $406 |
| Notes receivable, net | 343 | 343 |
| Other | 226 | 67 |
| Total receivables | $4,914 | $816 |
The components of accounts payable and accrued liabilities are as follows:
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Accounts payable | $3,706 | $1,006 |
| Accrued operating expenses | 1,022 | 4,391 |
| Accrued payroll liabilities | 3,078 | 4,162 |
| Accrued capital expenditures | 12 | 205 |
| Accrued taxes | 395 | 393 |
| Other accrued liabilities | — | 4 |
| Accounts payable and accrued liabilities | $8,213 | $10,161 |
- COMMITMENTS AND CONTINGENCIES
General Legal Matters
Other than routine litigation incidental to our business, or as described below, the Company is not currently a party to any material pending legal proceedings that management believes would be likely to have a material adverse effect on our financial position, results of operations or cash flows.
White Mesa Mill
In 2011, the Ute Mountain Ute Tribe filed an administrative appeal of the State of Utah Division of Air Quality’s (“UDAQ”) decision to approve a Modification to the Air Quality Approval Order at the Mill. Then, in 2013, the Ute Mountain Ute Tribe filed a Petition to Intervene and Request for Agency Action challenging the Corrective Action Plan approved by the State of Utah Department of Environmental Quality (“UDEQ”) relating to nitrate contamination in the shallow aquifer at the Mill. In August 2014, the Ute Mountain Ute Tribe filed an administrative appeal to the State of Utah Division of Radiation Control’s (“DRC”) Radioactive Materials License Amendment 7 approval regarding alternate feed material from Dawn Mining. The challenges remain open at this time and may involve the appointment of an administrative law judge (“ALJ”) to hear the matters. The Company does not consider these actions to have any merit. If the petitions are successful, the likely outcome would be a requirement to modify or replace the existing Air Quality Approval Order, Corrective Action Plan or license amendment, as applicable. At this time, the Company does not believe any such modifications or replacements would materially affect its financial position, results of operations or cash flows. However, the scope and costs of remediation under a revised or replaced Air Quality Approval Order, Corrective Action Plan and/or license amendment have not yet been determined and could be significant.
The UDEQ renewed in January 2018, then reissued with minor corrections in February 2018, the Mill’s radioactive materials license (the “Mill License”) for another ten years and the Groundwater Discharge Permit (the “GWDP”) for another five years, after which further applications for renewal of the Mill License and GWDP are required to be submitted. During the review period for each application for renewal, the Mill can continue to operate under its existing Mill License and GWDP until such time as the renewed Mill License or GWDP is issued. Most recently, on July 15, 2022, the routine GWDP renewal application was submitted to UDEQ, which remains under consideration at this time.
In 2018, the Grand Canyon Trust, Ute Mountain Ute Tribe and Uranium Watch (collectively, the “Mill Plaintiffs”) served Petitions for Review challenging UDEQ’s renewal of the Mill License and GWDP and Requests for Appointment of an ALJ, which they later agreed to suspend pursuant to a Stipulation and Agreement with UDEQ, effective June 4, 2018. The Company and the Mill Plaintiffs held multiple discussions over the course of 2018 and 2019 in an effort to settle the dispute outside of any judicial proceeding. In February 2019, the Mill Plaintiffs submitted to the Company their proposal for reaching a settlement agreement. The proposal remains under consideration by the Company. The Company does not consider these challenges to have any merit and, if a settlement cannot be reached, the Company intends to participate with UDEQ in defending against the challenges. If the challenges are successful, the likely outcome would be a requirement to modify the renewed Mill License and/or GWDP. At this time, the Company does not believe that any such modification would materially affect its financial position, results of operations or cash flows.
On August 26, 2021, the Ute Mountain Ute Tribe filed a Petition to Intervene and Petition for Review challenging the UDEQ’s approval of Amendment No. 10 to the Mill License, which expanded the list of Alternate Feed Materials that the Mill is authorized to accept and process for its source material content. Then, on November 18, 2021, the Tribe filed its Request for
Appointment of an ALJ, followed shortly thereafter by a stay on the request in accordance with a Stipulation and Agreement between the Tribe, UDEQ and Company. Thereafter, discussions between the Company and the Tribe commenced in an effort to resolve the dispute and other outstanding matters without formal adjudication. However, the Company does not consider this action to have any merit. If resolution is not achieved, the stay is lifted and the petition is successful before an ALJ, the likely outcome would be a requirement to modify or revoke the Mill License amendment. At this time, the Company does not believe any such modification or revocation would materially affect its financial position, results of operations or cash flows.
Mineral Property Commitments
The Company enters into commitments with federal and state agencies and private individuals to lease mineral rights. These leases are renewable annually, and, as reported in the Company’s Form 10-K for the year ended December 31, 2023, renewal costs for the remainder of 2024 are expected to total approximately $0.23 million.
Surety Bonds
The Company has indemnified third-party companies to provide surety bonds as collateral for the Company’s asset retirement obligations (“AROs”). The Company is obligated to replace this collateral in the event of a default and is obligated to repay any reclamation or closure costs due. As of September 30, 2024, the Company has $19.28 million posted as collateral against undiscounted AROs of $33.71 million. As of December 31, 2023, the Company has $17.58 million posted as collateral against undiscounted AROs of $33.38 million. The Company will be liable to pay any reclamation expense that exceeds the amount of the collateral posted against the surety bonds.
Commitments
The Company is contractually obligated under a Sales and Agency Agreement appointing an exclusive sales and marketing agent for all vanadium pentoxide produced by the Company.
- FAIR VALUE ACCOUNTING
Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
Fair value accounting utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below:
Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;
Level 2 – Quoted prices in markets that are not active, or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability; and
Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).
The Company’s financial instruments as of September 30, 2024 and December 31, 2023 include cash, cash equivalents, restricted cash, accounts receivable, accounts payable and current accrued liabilities. These instruments are carried at cost, which approximates fair value due to the short-term maturities of the instruments. Allowances for doubtful accounts are recorded against the accounts receivable balance to estimate net realizable value.
The Company’s investments in marketable equity securities are publicly traded stocks measured at fair value and classified within Level 1 and Level 2 in the fair value hierarchy. Level 1 marketable equity securities use quoted prices for identical assets in active markets, while Level 2 marketable equity securities utilize inputs based upon quoted prices for similar instruments in active markets. The Company’s investments in marketable debt securities are valued using quoted prices of a pricing service and, as such, are classified within Level 2 of the fair value hierarchy. The Company’s investments accounted for at fair value consisting of common shares are valued using quoted market prices in active markets and, as such, are classified within Level 1 of the fair value hierarchy. The Company’s investments include certain investments accounted for at fair value consisting of warrants are valued using the Black-Scholes option model based on observable inputs and, as such, are classified within Level 2 of the hierarchy.
The Convertible Note received as part of the Alta Mesa Transaction was valued as of February 14, 2023, upon closing, using a binomial lattice model. The fair value calculation used significant unobservable inputs within the Level 3 fair value hierarchy, including: (i) volatility 60%, and (ii) yield of 9.5%. Increases or decreases in the volatility and/or the selected yield can result in an increase or decrease in the fair value of the Convertible Note. Between February 14, 2023 and November 3, 2023, enCore early redeemed $40.00 million of the principal value of the Convertible Note. On November 9, 2023, the Company sold the remaining unpaid balance of $20 million owed under the secured Convertible Note for total consideration of $21.00 million plus $1.50 million in unpaid accrued interest, less a sales commission of $0.10 million paid to a third-party broker. As a result of enCore’s earlier pay-down and the $22.40 million received in connection with the sale of the Convertible Note, the Company received payment in full for the Alta Mesa Transaction, and no further consideration is owed in connection therewith.
The Company used the discounted cash flow approach, which is an income statement technique, to estimate the fair value of the its contingent consideration payment to RadTran using an indicated discount rate of 10.2%, as of the acquisition date, August 16, 2024 and 8.2% as of September 30, 2024, which is based on significant inputs not observable in the market, and thus represents a Level 3 measurement within the fair value hierarchy.
The following tables set forth the fair value of the Company’s assets and liabilities measured at fair value on a recurring basis (at least annually) by level within the fair value hierarchy. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
| Level 1 | Level 2 | Level 3 | Total | |
|---|---|---|---|---|
| Assets | ||||
| Cash equivalents(1) | $— | $18,468 | $— | $18,468 |
| Marketable debt securities | — | 77,333 | — | 77,333 |
| Marketable equity securities | 23,742 | 79 | — | 23,821 |
| Total assets | $23,742 | $95,880 | $— | $119,622 |
| Liabilities | ||||
| Contingent consideration | — | — | 1,727 | 1,727 |
| Assets | ||||
| Cash equivalents(1) | $— | $40,512 | $— | $40,512 |
| Marketable debt securities | — | 107,466 | — | 107,466 |
| Marketable equity securities | 25,554 | 24 | — | 25,578 |
| $25,554 | $148,002 | $— | $173,556 | |
(1) Cash and cash equivalents are comprised of U.S. Treasury Bills, Government Agency Bonds, U.S. Non-Redeemable Term Deposits and mutual funds purchased within three months of their maturity date.
Changes in Level 3 Fair Value Measurements
The following table is a reconciliation of the beginning and ending balance recorded for the contingent consideration classified as Level 3 in the fair value hierarchy:
| Beginning balance, August 16, 2024 | $1,690 |
|---|---|
| Increase to intellectual property | 37 |
| Ending balance, September 30, 2024 | $1,727 |
Investments Accounted for at Fair Value
The fair value of investments accounted for at fair value was calculated as the quoted market price of the marketable equity security multiplied by the quantity of shares held by the Company. During the nine months ended September 30, 2023, the
Company held ownership interests in Virginia Energy Resources, Inc. (“Virginia Energy”) and Consolidated Uranium Inc. (“CUR”). These investments provided the Company with the ability to have significant influence, but not control, over their operations. The Company elected the fair value option for each of these investments.
On January 24, 2023, CUR acquired 100% of the issued and outstanding common shares of Virginia Energy for 0.26 common shares of CUR for every one common share of Virginia Energy. As a result, the Company’s 9,439,857 common shares of Virginia Energy were converted into 2,454,362 million common shares of CUR (the “Conversion”). Following the Conversion, the Company owned 16,189,548 common shares of CUR, which represented an ownership interest of 16.7% in CUR as of closing.
On December 5, 2023, IsoEnergy Ltd. (“IsoEnergy”) acquired all of the issued and outstanding common shares of CUR (the “CUR Shares”). Pursuant to the arrangement, CUR’s shareholders received 0.500 common shares of IsoEnergy for every CUR Share. When converted, the Company's CUR Shares result in an approximate ownership interest in IsoEnergy of 5.0%. On October 19, 2023, IsoEnergy completed its marketed private placement offering of 8,134,500 subscription receipts of IsoEnergy (the “Subscription Receipts”) at a price of Cdn$4.50 per Subscription Receipt; in order to retain its post-arrangement ownership interest in IsoEnergy, the Company purchased 406,650 Subscription Receipts for Cdn$1.83 million. Each outstanding Subscription Receipt was converted into one common share of IsoEnergy. Following completion of this arrangement, the Company owned 8,501,424 shares of IsoEnergy for an approximate ownership interest of 5.0% as of December 5, 2023.
Upon completion of this arrangement, the Company does not have significant influence over IsoEnergy as a result of no representation on the Board of Directors of IsoEnergy and its reduced ownership interest. Therefore, the investment is no longer accounted for as an equity method investment. The Company's judgment regarding the level of influence over its equity method investments includes considering key factors such as the Company's ownership interest, representation on the Board of Directors and participation in the policy-making decisions of equity method investees. As such, the Company's shares in IsoEnergy are accounted for as marketable securities with the fair value option elected on its Consolidated Balance Sheet and changes in value are included in Other income (loss) in the Consolidated Statement of Operations and Comprehensive Income.
The Company had an unrealized gain of $8.89 million and $6.70 million, respectively, for the three and nine months ended September 30, 2023. The unrealized gain (loss) related to these investments is included in Other income in the Condensed Consolidated Statement of Operations and Comprehensive Income.
- REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS
All revenue recognized is a result of contracts with customers by way of uranium, vanadium and RE Carbonate sales contracts, Alternate Feed Material processing contracts and/or byproduct disposal agreements with other ISR facilities. As of September 30, 2024 and December 31, 2023, the Company's receivables from its contracts with customers was $4.35 million and $0.41 million, respectively.
Uranium Concentrates
The Company's sales of uranium concentrates are derived from contracts with major U.S. utilities. Revenue is recognized when delivery is evidenced by book transfer at the applicable uranium storage facility. The sales contracts specify the quantity to be delivered, the price, payment terms and the year of delivery. The Company's agreements with major U.S. utilities have terms greater than one year. The Company is not required to disclose the transaction price allocated to remaining performance obligations because the variable consideration is allocated entirely to a wholly unsatisfied performance obligation. Under these contracts, each delivery product transferred to the customer represents a separate performance obligation; therefore, future quantities are wholly unsatisfied and disclosure of the transaction price allocated to remaining performance obligations is not required.
The Company will also sell uranium concentrate to the U.S. Uranium Reserve or other third parties, and such contracts are short-term in nature with a contract term of one year or less. Accordingly, the Company is exempt from disclosure of the transaction price allocated to remaining performance obligations if the performance obligation is part of a contract that has an original expected duration of one year or less.
Under the Company's uranium contracts, it invoices customers after the performance obligations have been satisfied, at which point payment is unconditional. Accordingly, the Company’s uranium contracts do not give rise to contract assets or liabilities.
Vanadium Concentrates
The Company's sales of vanadium concentrates are recognized when delivery is evidenced by book transfer at the applicable vanadium storage facility. Under the Company's vanadium contracts, it invoices customers after the performance obligations have been satisfied, at which point payment is unconditional. Accordingly, the Company’s vanadium contracts do not give rise to contract assets or liabilities.
The Company’s sales of RE Carbonate revenue is recognized when delivery of the mixed RE Carbonate material has arrived at the applicable separation facility. Additionally, the Company will recognize revenue when the customer further processes the product from the RE Carbonate that the Company delivered and it is sold to a third party. Additionally, under this contract, each delivered product transferred to the customer represents a separate performance obligation; therefore, future volumes are wholly unsatisfied and disclosure of the transaction price allocated to remaining performance obligations is not required. Accordingly, the Company’s contracts do not give rise to contract assets or liabilities.
Alternate Feed Materials
Revenue from the delivery of mineralized material received from the clean-up of a third-party uranium mine or for Alternate Feed Materials is typically recognized upon delivery to the Mill. Revenue from toll milling services is recognized as material is processed in accordance with the specifics of the applicable toll milling agreement. Revenue and unbilled accounts receivable are recorded as related costs are incurred using billing formulas included in the applicable toll milling agreement.
- RELATED PARTY TRANSACTIONS
Robert W. Kirkwood, a member of the Company’s Board of Directors, is a principal of the Kirkwood Companies, including Kirkwood Oil and Gas LLC, Wesco Operating, Inc. and United Nuclear LLC (“United Nuclear”). United Nuclear owns a 19% interest in the Company’s Arkose Mining Venture, while the Company owns the remaining 81%. The Company acts as manager of the Arkose Mining Venture and has management and control over operations carried out by the Arkose Mining Venture. The Arkose Mining Venture is a contractual joint venture governed by a venture agreement dated as of January 15, 2008 and entered into by United Nuclear and Uranerz Energy Corporation, a wholly owned, indirectly held subsidiary of the Company.
On October 27, 2021, after closing on the sale of certain conventional uranium assets to CUR, the Company began providing services to CUR under a mine operating agreement. Pursuant to that agreement, the Company earned $0.01 million and $0.06 million for the three months ended September 30, 2024 and 2023, respectively. The Company earned $0.04 million and $0.52 million during the nine months ended September 30, 2024 and 2023, respectively under this agreement. As of September 30, 2024 and December 31, 2023, less than $0.01 million and $0.05 million was due from CUR, respectively. Additionally, the Company accrued $0.76 million and $1.53 million as of September 30, 2024 and December 31, 2023, respectively, in Other long-term receivables related to deferred cash payments for production thresholds pursuant to the terms of the asset purchase agreement with CUR.
- SUBSEQUENT EVENTS
Acquisition of Base Resources
On October 2, 2024, EFR Australia Pty Ltd (“EFR”), a wholly owned subsidiary of the Company, completed the acquisition of all of the fully paid ordinary shares (the “Transaction”) of Base Resources pursuant to a Scheme Implementation Deed dated April 21, 2024 by and among the Company, EFR and Base Resources (the “Deed”).
Under the Deed, at closing, each holder of ordinary shares of Base Resources received consideration of (i)0.0260 Company common shares for each Base Resources share held on the Scheme Record Date (being 5 pm Perth, Australia time on Wednesday, September 18, 2024) (the “Share Consideration”), and (ii) AUS$0.065 in cash, paid by way of a special dividend by Base Resources to its shareholders. The total Share Consideration issued by Energy Fuels was approximately $178.44 million and the total special dividend value was approximately $55.08 million. Holders of ordinary shares of Base Resources that reside in certain jurisdictions will receive the net proceeds from the sale of the Company’s common shares by a nominee in lieu of the Share Consideration.
Base Resources owns the Toliara HMS and monazite project in Madagascar (the “Toliara Project”). The Toliara Project is a world-class, advanced-stage, low-cost, and large-scale HMS project. In addition to its stand-alone, ilmenite and rutile (titanium) and zircon (zirconium) production capability, the Toliara Project also contains large quantities of monazite, which is a rich source of the ‘magnetic’ REEs used in EVs and a variety of clean energy, defense and advanced technologies, as well as a source of recoverable uranium, which, upon development, would be shipped to the Mill for the recovery of REEs and the contained uranium. The Toliara Project is subject to negotiation of fiscal terms with the Madagascar government and the receipt of certain Madagascar government approvals and actions before a current suspension on activities at the Toliara Project will be lifted and development may occur. Base Resources also owns the Kwale HMS project in Kenya, which is nearing completion of its mine life and commencement of reclamation activities.
The Company expects the Transaction to be accounted for as a business combination using the acquisition method of accounting in accordance with ASC 805. Due to the proximity of the acquisition date to the filing of the Quarterly Report on Form 10-Q for the period ended September 30, 2024, the initial accounting for the Transaction is incomplete, and therefore, the Company is unable to disclose certain information required by ASC 805, including the provisional amounts recognized as of the acquisition date for fair value of consideration transferred, each major class of assets acquired and liabilities assumed, and goodwill, if any, due to the ongoing status of the valuation.
In January 2018, Base Resources completed the acquisition of the Toliara Project in Madagascar, with payment of $75.00 million in up-front consideration, for an initial 85% interest. In January 2020, in accordance with the terms of the share sale agreement with World Titane Holdings Limited, the Group acquired the remaining minority interest in the Toliara Project. A further $16.83 million (deferred consideration) is payable on achievement of key milestones. As a result of the transition, a change of control occurred, and payment of the $16.83 million deferred consideration accelerated and was paid on October 16, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.